| Enrolling By Invitation | Virtual Reality Sickness Questionnaire: Psychometrics in Stroke Patients NCT07297862 | Abant Izzet Baysal University | — |
| Completed | The Minimum Effective Dose (ED90) of Liposomal Bupivacaine for Preserving Motor Function NCT06587386 | Affiliated Hospital of Jiaxing University | Phase 4 |
| Recruiting | Evaluation of a Device to Reduce Motion Sickness and Spatial Disorientation NCT06892340 | 59th Medical Wing | N/A |
| Active Not Recruiting | Three-Axis Wearable Adaptive Vestibular Stimulator NCT06106256 | Mayo Clinic | N/A |
| Completed | Vestibulo-Ocular Reflex Function in Individuals With Chronic Motion Sensitivity Cross-Sectional Study NCT06128707 | Loma Linda University | — |
| Completed | Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness NCT05903924 | Vanda Pharmaceuticals | Phase 3 |
| Completed | Impact of Different Types of Virtual Reality Games on Motion Sickness and Ocular in Adults: A Pilot Study NCT06354309 | He Eye Hospital | N/A |
| Active Not Recruiting | Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness NCT06138613 | Vanda Pharmaceuticals | Phase 3 |
| Completed | Motion Sickness Rehabilitation for Virtual Reality NCT06056622 | Abant Izzet Baysal University | N/A |
| Withdrawn | Sensory Training for Orientation and Balance NCT04331561 | University of Wisconsin, Madison | N/A |
| Completed | Preliminary Evaluation of an Osteopathic Manipulative Treatment (OMT) to Prevent Motion Sickness Symptoms NCT05611814 | United States Army Aeromedical Research Laboratory | N/A |
| Completed | Efficacy and Safety of DPI-386 Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion NCT05548270 | Repurposed Therapeutics, Inc. | Phase 3 |
| Recruiting | StableEyes With Active Neurofeedback NCT05622344 | Johns Hopkins University | N/A |
| Completed | Gynecologic Endoscopic Surgery of Female Motion Sickness Patients NCT06232785 | Second Hospital of Jilin University | Phase 4 |
| Completed | Nebulizer Delivery of Intranasal Scopolamine NCT04999449 | Dartmouth-Hitchcock Medical Center | Phase 1 |
| Recruiting | Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sicknes NCT05886660 | Repurposed Therapeutics, Inc. | Phase 2 |
| Completed | Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness NCT04327661 | Vanda Pharmaceuticals | Phase 3 |
| Completed | Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion NCT04947423 | Repurposed Therapeutics, Inc. | Phase 3 |
| Completed | Sensory Training for Visual Motion Sickness NCT04420949 | University of Wisconsin, Madison | N/A |
| Withdrawn | Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma NCT04196933 | Massachusetts Eye and Ear Infirmary | N/A |
| Completed | Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness NCT04184115 | Repurposed Therapeutics, Inc. | Phase 3 |
| Completed | Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects NCT03988530 | Repurposed Therapeutics, Inc. | Phase 3 |
| Completed | The Prevention and Treatment of Nausea Associated With Motion Sickness NCT03986905 | Repurposed Therapeutics, Inc. | Phase 3 |
| Unknown | Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion Sickness NCT04272255 | Repurposed Therapeutics, Inc. | Phase 3 |
| Completed | Clinical Evaluation of the Use of Ginger Extract in the Management of Motion Sickness NCT03755596 | Fundação Educacional Serra dos Órgãos | Phase 4 |
| Completed | Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness NCT03772340 | Vanda Pharmaceuticals | Phase 2 |
| Terminated | DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness NCT04219982 | Repurposed Therapeutics, Inc. | Phase 2 / Phase 3 |
| Unknown | Motion Sickness Desensitization Using VR NCT05628220 | University Hospital, Caen | N/A |
| Unknown | Research on Quantification of VR(Virtual Reality) Related Stress and Relaxation NCT02986555 | Samsung Medical Center | N/A |
| Completed | Galvanic Vestibular Stimulation as a Novel Treatment for Seasickness NCT05004818 | Medical Corps, Israel Defense Force | N/A |
| Completed | A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery NCT02839135 | GlaxoSmithKline | Phase 1 |
| Completed | Levo Phencynonate Hydrochloride for the Prevention of Seasickness NCT02241629 | Sihuan Pharmaceutical Holdings Group Ltd. | Phase 2 |
| Terminated | Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray NCT02155309 | Repurposed Therapeutics, Inc. | Phase 2 / Phase 3 |
| Completed | Effects of Transdermal Scopolamine on Occupational Performance NCT00374478 | Boston University | Phase 2 |